Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Clinical Neuroradiology
Erschienen in: Clinical Neuroradiology 1/2012

01.03.2012 | Review article

Anticoagulation in Neurointerventions

Basic Pharmacology and Pathophysiology, Current Status, Practical Advice

verfasst von: J. Scharf, PhD, MD, C.-E. Dempfle, PhD, MD

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

This article gives an overview of anticoagulative medication accompanying neurointerventional procedures. The basic pharmacology of prevalent medication is outlined and the thrombogenicity of standard procedures is described. A brief overview of the literature on risks and benefits of standard medications and their monitoring is provided. A customized regime of care is presented.
Literatur
1.
Bonati LH, Fraedrich G, Carotid Stenting Trialists Collaboration. Age modifies the relative risk of stenting versus endarterectomy for symptomatic carotid stenosis—a pooled analysis of EVA-3S, SPACE and ICSS. Eur J Vasc Endovasc Surg. 2011;41(2):153–8.PubMedCrossRef
2.
SPACE Collaborative Group, Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368(9543):1239–47.PubMedCrossRef
3.
Zahn R, Ischinger T, Hochadel M, Mark B, Zeymer U, Schmalz W, et al. Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Catheter Cardiovasc Interv. 2009;74(1):1–8.PubMedCrossRef
4.
Zhu L, Wintermark M, Saloner D, Fandel M, Pan XM, Rapp JH. The distribution and size of ischemic lesions after carotid artery angioplasty and stenting: evidence for microembolization to terminal arteries. J Vasc Surg. 2011;53(4):971–5.PubMedCrossRef
5.
Shapiro M, Babb J, Becske T, Nelson PK. Safety and efficacy of adjunctive balloon remodeling during endovascular treatment of intracranial aneurysms: a literature review. AJNR Am J Neuroradiol. 2008;29(9):1777–81.PubMedCrossRef
6.
Bendszus M, Koltzenburg M, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet. 1999;354(9190):1594–7.PubMedCrossRef
7.
Brockmann C, Hoefer T, Diepers M, Neumaier-Probst E, Noelte I, Brockmann MA, et al. Abciximab does not prevent ischemic lesions related to cerebral angiography: a randomized placebo-controlled trial. Cerebrovasc Dis. 2011;31(4):353–7.PubMedCrossRef
8.
Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME. Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol. 2008;29(7):1389–94.PubMedCrossRef
9.
Prandoni P, Siragusa S, Girolami B, Fabris F. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood. 2005;106(9):3049–54.PubMedCrossRef
10.
Thiex R, Norbash AM, Frerichs KU. The safety of dedicated-team catheter-based diagnostic cerebral angiography in the era of advanced noninvasive imaging. AJNR Am J Neuroradiol. 2010;31(2):230–4.PubMedCrossRef
11.
Sorimachi T, Nishino K, Shimbo J, Morita K, Ito Y, Fujii Y. Routine use of debris aspiration before retrieval of distal filter protection devices in carotid arterial stenting: analysis of captured debris and evaluation of clinical results. Neurosurgery. 2010;67(5):1260–7.PubMedCrossRef
12.
Tallarita T, Rabinstein AA, Cloft H, Kallmes D, Oderich GS, Brown RD, et al. Are distal protection devices “protective” during carotid angioplasty and stenting? Stroke. 2011;42(7):1962–6.PubMedCrossRef
13.
Jansen O, Fiehler J, Hartmann M, Bruckmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE trial. Stroke. 2009;40(3):841–6.PubMedCrossRef
14.
Harnek J, Zoucas E, Carlemalm E, Cwikiel W. Differences in endothelial injury after balloon angioplasty, insertion of balloon-expanded stents or release of self-expanding stents: an electron microscopic experimental study. Cardiovasc Interv Radiol. 1999;22(1):56–61.CrossRef
15.
Edelman ER, Rogers C. Pathobiologic responses to stenting. Am J Cardiol. 1998;81(7A):4E–6E.PubMedCrossRef
16.
Perez De Prado A, Perez Martinez C, Cuellas Ramon C, Gonzalo Orden JM, Altonaga JR, Iglesias MJ, et al. Endothelialization of nonapposed stent struts located over the origin of a side branch: results with different carbofilm-coated stents. J Interv Cardiol. 2009;22(3):222–7.PubMedCrossRef
17.
Ong AT, Aoki J, Kutryk MJ, Serruys PW. How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss. 2005;98(2):123–6.PubMed
18.
Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation. 2004;109(2):220–6.PubMedCrossRef
19.
Kolandaivelu K, Swaminathan R, Gibson WJ, Kolachalama VB, Nguyen-Ehrenreich KL, Giddings VL, et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation. 2011;123(13):1400–9.PubMedCrossRef
20.
Schillinger M, Gschwendtner M, Reimers B, Trenkler J, Stockx L, Mair J, et al. Does carotid stent cell design matter? Stroke. 2008;39(3):905–9.PubMedCrossRef
21.
Gröschel K, Schnaudigel S, Ernemann U, Wasser K, Kastrup A. Size matters! Stent-length is associated with thrombembolic complications after carotid artery stenting. Stroke. 2008;39(8):e131–2; author reply e3.PubMedCrossRef
22.
Han MH, Kwon OK, Yoon CJ, Kwon BJ, Cha SH, Chang KH. Gas generation and clot formation during electrolytic detachment of Guglielmi detachable coils: in vitro observations and animal experiment. AJNR Am J Neuroradiol. 2003;24(3):539–44.PubMed
23.
Henkes H, Brew S, Felber S, Miloslavski E, Mogilevski G, Tavrovski I, et al. In vitro and in vivo studies of the extent of electrothrombotic deposition of blood elements on the surface of electrolytically detachable coils. Interv Neuroradiol. 2004;10(3):189–201.PubMed
24.
Yonaha H, Hyodo A, Inaji T, Ito K, Kushi S, Tsuchida K, et al. Thromboembolic events associated with coil protrusion into parent arteries after GDC treatment. Interv Neuroradiol. 2006;12(Suppl 1):105–11.PubMed
25.
Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol. 1998;19(8):1541–7.PubMed
26.
Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost. 2008;34(1):58–73.PubMedCrossRef
27.
Narins CR, Hillegass WB, Jr., Nelson CL, Tcheng JE, Harrington RA, Phillips HR, et al. Relation between activated clotting time during angioplasty and abrupt closure. Circulation. 1996;93(4):667–71.PubMed
28.
Hermanides RS, Ottervangerl JP,Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT, et al. Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction. Thromb Haemost. 2011;106:636–40.PubMedCrossRef
29.
Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a standard care nomogram—a randomized controlled trial. Ann Intern Med. 1993;119(9):874–81.PubMed
30.
Schlicht JR, Sunyecz L, Weber RJ, Tabas GH, Smith RE. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary? Ann Pharmacother. 1997;31(12):1454–9.PubMed
31.
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–60.PubMedCrossRef
32.
Brockmann C, Seker F, Weiss C, Groden C, Scharf J. Acetylsalicylic acid does not prevent digital subtraction angiography-related high signal intensity lesions in diffusion-weighted imaging in cerebrovascular patients: a retrospective analysis. Clin Neuroradiol. 2011. Epub ahead of print.
33.
Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med. 1992;327(3):175–81.PubMedCrossRef
34.
Dorffler-Melly J, Koopman MM, Prins MH, Buller HR. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev. 2005(1):CD002071.
35.
Fiehler J, Ries T. Prevention and treatment of thromboembolism during endovascular aneurysm therapy. Clin Neuroradiol-Klin Neuroradiol. 2009;19(1):73–81.
36.
Yamada NK, Cross DT 3rd, Pilgram TK, Moran CJ, Derdeyn CP, Dacey RG Jr. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol. 2007;28(9):1778–82.PubMedCrossRef
37.
Ries T, Buhk JH, Kucinski T, Goebell E, Grzyska U, Zeumer H, et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke. 2006;37(7):1816–21.PubMedCrossRef
38.
Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Harmsze AM, Hackeng CM, et al. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Heart. 2011;97(12):983–90.PubMedCrossRef
39.
Eshtehardi P, Windecker S, Cook S, Billinger M, Togni M, Garachemani A, et al. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation. Am Heart J. 2010;159(5):891–8.PubMedCrossRef
40.
Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA. 2010;303(8):754–62.PubMedCrossRef
41.
Harjai KJ, Shenoy C, Orshaw P, Usmani S, Singh M, Boura J, et al. Low-dose versus high-dose aspirin after percutaneous coronary intervention. J Am Coll Cardiol. 2011;57(14):1911.CrossRef
42.
Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet. 2010;376(9748):1233–43.PubMedCrossRef
43.
Pusch G, Feher G, Kotai K, Tibold A, Gasztonyi B, Feher A, et al. Aspirin resistance: focus on clinical endpoints. J Cardiovasc Pharmacol. 2008;52(6):475–84.PubMedCrossRef
44.
Brambilla M, Parolari A, Camera M, Colli S, Eligini S, Centenaro C, et al. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. Thromb Haemost. 2010;103(3):516–24.PubMedCrossRef
45.
De Schryver E, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease (Withdrawn Paper. 2007, art. no. CD001820). Cochrane Database Syst Rev. 2007(3). doi:10.1002/14651858.CD001820.pub3.
46.
Uchiyama S, Ikeda Y, Urano Y, Horie Y, Yamaguchi T. The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: a randomized, double-blind, controlled trial. Cerebrovasc Dis. 2011;31(6):601–13.PubMedCrossRef
47.
Gent M, Beaumont D, Blanchard J, Bousser MG, Coffman J, Easton JD, et al. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329–39.CrossRef
48.
Berger K, Hessel F, Kreuzer J, Smala A, Diener HC. Clopidogrel versus aspirin in patients with atherothrombosis: CAPRI E-based calculation of cost-effectiveness for Germany. Curr Med Res Opin. 2008;24(1):267–74.PubMed
49.
Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ, Dutro MP, et al. Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. Am J Ther. 2010;17(2):167–75.PubMedCrossRef
50.
Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, et al. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation. Health Technol Assess. 2004;8(40):1–141.
51.
Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007;115(25):3156–64.PubMedCrossRef
52.
Kang H-S, Han MH, Kwon BJ, Jung C, Kim J-E, Kwon OK, et al. Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? Neurosurgery. 2010;67(5):1371–6.PubMedCrossRef
53.
Kang HS, Kwon BJ, Kim JE, Han MH. Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications. Am J Neuroradiol. 2010;31(7):1206–10.PubMedCrossRef
54.
Cuisset T, Quilici J, Cohen W, Fourcade L, Saut N, Pankert M, et al. Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome. Am J Cardiol. 2011. Epub ahead of print.
55.
Achar S. Pharmacokinetics, drug metabolism, and safety of prasugrel and clopidogrel. Postgrad Med. 2011;123(1):73–9.PubMedCrossRef
56.
Reinhart KM, White CM, Baker WL. Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy. 2009;29(12):1441–51.PubMedCrossRef
57.
Hermosillo AJ, Spinler SA. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? Ann Pharmacother. 2008;42(6):790–805.PubMedCrossRef
58.
Jafri SM, Mehta TP. Periprocedural management of anticoagulation in patients on extended warfarin therapy. Semin Thromb Hemost. 2004;30(6):657–64.PubMedCrossRef
59.
Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA stroke survey. Circulation. 2002;105(14):1679–85.PubMedCrossRef
60.
Hermann A, Dzialowski I, Koch R, Gahn G. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? J Neurol Sci. 2009;284(1–2):155–7.PubMedCrossRef
61.
Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol. 1998;19(1):157–65.PubMed
62.
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360(9342):1267–74.PubMedCrossRef
63.
Deliargyris EN, Upadhya B, Applegate RJ, Kontos JL, Kutcher MA, Riesmeyer JS, et al. Safety of abciximab administration during PCI of patients with previous stroke. J Thromb Thrombolysis. 2005;19(3):147–53.PubMedCrossRef
64.
Ries T, Siemonsen S, Grzyska U, Zeumer H, Fiehler J. Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature. Stroke. 2009;40(5):1750–7.PubMedCrossRef
65.
Neubauer H, Kaiser AF, Endres HG, Kruger JC, Engelhardt A, Lask S, et al. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance–the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011;9:3.PubMedCrossRef
66.
Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.PubMedCrossRef
67.
Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10):e573–83.PubMedCrossRef
Metadaten
Titel
Anticoagulation in Neurointerventions
Basic Pharmacology and Pathophysiology, Current Status, Practical Advice
verfasst von
J. Scharf, PhD, MD
C.-E. Dempfle, PhD, MD
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Neuroradiology / Ausgabe 1/2012
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-012-0133-6

Weitere Artikel der Ausgabe 1/2012

Clinical Neuroradiology 1/2012 Zur Ausgabe

NEW in the Web

Quantitative Magnetic Resonance Angiography

Original Article

Endovascular Repositioning of a Pipeline Embolization Device Dislocated from the Vertebral into the Basilar Artery Using a Stent-in-Stent Technique

Correspondence

Multiple Cystic Brain Metastases from Adenocarcinoma Mimicking Cysticercosis

Information

Societies Communications for 22-1-2012

Original Article

Arterial Spin Labeling at 3.0 Tesla in Subacute Ischemia

Original Article

Magnetic Resonance Imaging Flow Quantification of Non-Occlusive Excimer Laser-Assisted EC-IC High-Flow Bypass in the Treatment of Complex Intracranial Aneurysms

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet

29.03.2024 | Diagnostische Radiologie | Nachrichten

Studie bestätigt Potenzial von KI in der Radiologie
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen